| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Canadian Journal of Infectious Diseases & Medical Microbiology LetPub Score 5.1
50 ratings
Rate
Reputation 5.9 Influence 3.8 Speed 8.7 | ||||||||||||||||||||
| 期刊簡稱 | CAN J INFECT DIS MED | ||||||||||||||||||||
| ISSN | 1712-9532 | ||||||||||||||||||||
| E-ISSN | 1918-1493 | ||||||||||||||||||||
| h-index | 32 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 3.80%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://www.hindawi.com/journals/cjidmm/ | ||||||||||||||||||||
| 在線稿件提交 | http://mts.hindawi.com/login/ | ||||||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||||||
| 出版商 | Hindawi Limited | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | CANADA | ||||||||||||||||||||
| 發行頻率 | 隔月刊行 | ||||||||||||||||||||
| 創刊年 | 2004 | ||||||||||||||||||||
| 每年文章數 | 67每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 98.84% | ||||||||||||||||||||
OA Related Info | APC: Yes（ USD2000; ） APC waiver：Check Notes Other charges: No Keywords: infectious diseases、immunology、antiobiotics、antiobiotic resistance Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q3
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1712-9532%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Canadian Journal of Infectious Diseases & Medical Microbiology] 的評論 | 撰寫評論 |
| 作者: 打怪升级 領域: 医学 審稿時間: 9.0 month(s) 結果: 拒稿 撰寫評論 |
2023-10-13 09:31:01 評論於 My advice is to accept the recommendation of the external audit expert, even though the editor rejected it  (0) 讚！ | 打怪升级  |
| 作者: 打怪升级 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-06-26 15:54:54 評論於 Invitation to review experts will start around June 19th. (0) 讚！ | 打怪升级 |
| 作者: 打怪升级 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-06-14 13:58:02 評論於 Submitted for revision on June 14th, showing "under review." (0) 讚！ | 打怪升级 |
| 作者: 打怪升级 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-06-09 21:15:31 評論於 June 8th: Upon logging into the system, I received minor suggestions for revision, but the academic editor has already made changes. The website displays modification suggestions given by external reviewers in early May. (0) 讚！ | 打怪升级 |
| 作者: 打怪升级 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-05-02 13:45:48 評論於 May 2nd: The review status has changed to pending approval. (0) 讚！ | 打怪升级 |
| 作者: 打怪升级 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-04-12 20:47:39 評論於 Submit the revised draft on March 15. The manuscript status changed from pending approval to under review on April 12. (0) 讚！ | 打怪升级 |
| 作者: 打怪升级 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-03-10 16:05:49 評論於 On the official website, I can see an email. May I ask, what was the final outcome for you, OP? (0) 讚！ | 打怪升级 |
| 作者: 打怪升级 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-03-10 15:14:29 評論於 December 11, 2022 submission March 7, 2023 major revision (0) 讚！ | 打怪升级 |
| 作者: lllxm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2023-03-06 13:03:53 評論於 Where can I see the reviewer's comments, please? (0) 讚！ | lllxm |
| 作者: 北固山下Aj 領域: 医学 審稿時間: 3.0 month(s) 結果: 待定＆不明 撰寫評論 |
2020-11-28 19:22:37 評論於 About 3 months after submission, the email of review comments requiring revision was received. About half a month later, the reviewer suggested to accept and publish the manuscript, but the academic editor rejected the manuscript. It is under appeal for now. The first time I encountered this kind of situation. (0) 讚！ | 北固山下Aj |
| 作者: Gallagher 領域: 医学 審稿時間: 5.0 month(s) 結果: 待定＆不明 撰寫評論 |
2019-01-14 17:50:27 評論於 The amount of documents is still too small, and the review period is slightly longer.Some. (0) 讚！ | Gallagher |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
